We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BHC market cap is 2.01B. The company's latest EPS is USD -0.1250 and P/E is -60.16.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.41B | 2.15B | 2.43B | 2.51B | 2.56B |
| Operating Income | 362M | 281M | 432M | 543M | 313M |
| Net Income | -39M | -64M | 10M | -85M | 93M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 8.03B | 8.43B | 8.12B | 8.76B | 9.63B |
| Operating Income | 676M | 450M | 454M | 963M | 1.55B |
| Net Income | -560M | -948M | -225M | -592M | -46M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 27.35B | 26.91B | 26.5B | 26.54B | 26.52B |
| Total Liabilities | 27.43B | 27.09B | 26.72B | 26.78B | 26.85B |
| Total Equity | -82M | -174M | -227M | -242M | -322M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 31.2B | 29.2B | 25.69B | 27.35B | 26.52B |
| Total Liabilities | 30.59B | 29.24B | 25.43B | 27.43B | 26.85B |
| Total Equity | 605M | -34M | 260M | -82M | -322M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.03B | 211M | 591M | 996M | 1.6B |
| Investing | -2.15B | -73M | -152M | -254M | -454M |
| Financing | 1.48B | -340M | -764M | -953M | -868M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.11B | 1.43B | -728M | 1.03B | 1.6B |
| Investing | -261M | 409M | -303M | -2.15B | -454M |
| Financing | -2.29B | -1.51B | -474M | 1.48B | -868M |
| Market Cap | 2.01B |
| Price to Earnings Ratio | -60.16 |
| Price to Sales Ratio | 0.29 |
| Price to Cash Ratio | 2.34 |
| Price to Book Ratio | -8.59 |
| Dividend Yield | - |
| Shares Outstanding | 367.93M |
| Average Volume (1 week) | 2.73M |
| Average Volume (1 Month) | 3.19M |
| 52 Week Change | -35.92% |
| 52 Week High | 9.85 |
| 52 Week Low | 3.96 |
| Spread (Intraday) | 0.11 (2.01%) |
| Company Name | Bausch Health Companies Inc |
| Address |
2150 st. elz��ar blvd. west quebec city, quebec H7L 4A8 |
| Website | https://www.bauschhealth.com |
| Industry | drugs (2830) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
